TPG Capital To Acquire Immucor For $1.97 B

Immucor Inc BLUD agreed to be bought by TPG Capital in a deal worth $1.97 billion or $27 per share in cash.. The price represents a 30% premium over BLUD's closing share price on July 1. The transaction is likely to close in the second half of this year. The deal was unanimously approved by the Immucor board of directors. BLUD shares gained 1.52% to close at $20.73 on Friday. Read more from Benzinga's Company news.